132 related articles for article (PubMed ID: 22752532)
1. Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice.
Rubin RF; Kuttab HM; Rihani RS; Reutzel TJ
J Community Health; 2012 Dec; 37(6):1145-50. PubMed ID: 22752532
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with human papillomavirus vaccination completion on a catch-up schedule.
Perry R; Rankin K; Yu MC; Harwood B
Obstet Gynecol; 2014 Jul; 124(1):76-81. PubMed ID: 24901268
[TBL] [Abstract][Full Text] [Related]
3. HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.
Liu G; Kong L; Du P
Papillomavirus Res; 2016 Dec; 2():1-8. PubMed ID: 26623444
[TBL] [Abstract][Full Text] [Related]
4. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of using standing orders to deliver human papillomavirus vaccines in the outpatient obstetrician/gynecologist setting.
Dempsey AF; Pyrzanowski J; Brewer S; Barnard J; Sevick C; O'Leary ST
Vaccine; 2015 Apr; 33(15):1773-9. PubMed ID: 25731788
[TBL] [Abstract][Full Text] [Related]
6. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA
J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357
[TBL] [Abstract][Full Text] [Related]
7. A randomized intervention of reminder letter for human papillomavirus vaccine series completion.
Chao C; Preciado M; Slezak J; Xu L
J Adolesc Health; 2015 Jan; 56(1):85-90. PubMed ID: 25438965
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus Infection and Vaccination.
Valentino K; Poronsky CB
J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
[TBL] [Abstract][Full Text] [Related]
9. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
Adjei Boakye E; Lew D; Muthukrishnan M; Tobo BB; Rohde RL; Varvares MA; Osazuwa-Peters N
Hum Vaccin Immunother; 2018; 14(8):2016-2024. PubMed ID: 29708826
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated With HPV Vaccine Initiation, Vaccine Completion, and Accuracy of Self-Reported Vaccination Status Among 13- to 26-Year-Old Men.
Thomas R; Higgins L; Ding L; Widdice LE; Chandler E; Kahn JA
Am J Mens Health; 2018 Jul; 12(4):819-827. PubMed ID: 27106515
[TBL] [Abstract][Full Text] [Related]
11. The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series.
Harper DM; Verdenius I; Harris GD; Barnett AL; Rosemergey BE; Arey AM; Wall J; Malnar GJ
Prev Med; 2014 Apr; 61():20-5. PubMed ID: 24440159
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus Vaccination Schedule: Adherence Among Commercially Insured Adolescents and Young Adults in the United States, 2011-2017.
Hubbard D; Shrestha S; Levitan EB; Yun H
Am J Public Health; 2020 Mar; 110(3):385-390. PubMed ID: 31944848
[No Abstract] [Full Text] [Related]
13. Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities.
Richards MJ; Peters M; Sheeder J
J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):117-21. PubMed ID: 26300233
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial.
Neuzil KM; Canh DG; Thiem VD; Janmohamed A; Huong VM; Tang Y; Diep NT; Tsu V; LaMontagne DS
JAMA; 2011 Apr; 305(14):1424-31. PubMed ID: 21486975
[TBL] [Abstract][Full Text] [Related]
15. Acceptance and compliance with postpartum human papillomavirus vaccination.
Wright JD; Govindappagari S; Pawar N; Cleary K; Burke WM; Devine PC; Lu YS; Tsai WY; Lewin SN; Herzog TJ
Obstet Gynecol; 2012 Oct; 120(4):771-82. PubMed ID: 22996094
[TBL] [Abstract][Full Text] [Related]
16. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009.
Dorell CG; Stokley S; Yankey D; Markowitz LE
Vaccine; 2012 Jan; 30(3):503-5. PubMed ID: 22119587
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents.
Gerend MA; Stephens YP; Kazmer MM; Slate EH; Reyes E
J Adolesc Health; 2019 Jun; 64(6):753-762. PubMed ID: 30777636
[TBL] [Abstract][Full Text] [Related]
18. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
Olsson SE; Villa LL; Costa RL; Petta CA; Andrade RP; Malm C; Iversen OE; Høye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; von Krogh G; Lehtinen M; Paavonen J; Tamms GM; Giacoletti K; Lupinacci L; Esser MT; Vuocolo SC; Saah AJ; Barr E
Vaccine; 2007 Jun; 25(26):4931-9. PubMed ID: 17499406
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study.
Silverberg MJ; Leyden WA; Lam JO; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF
Lancet Child Adolesc Health; 2018 Oct; 2(10):707-714. PubMed ID: 30236379
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs.
Markowitz LE; Drolet M; Perez N; Jit M; Brisson M
Vaccine; 2018 Aug; 36(32 Pt A):4806-4815. PubMed ID: 29802000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]